ORG Wealth Partners’s Oric Pharmaceuticals ORIC Stock Holding History

ORG Wealth Partners’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$80	Buy	+6	New	+$75	﹤0.01%	2476

Other funds holding ORIC

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Pfizer New York $164M AUM 53.62% 1-Year Est. Return

ORG Wealth Partners's ORIC Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 6 shares worth $80. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings.

73 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

ORG Wealth Partners held 6 shares of Oric Pharmaceuticals worth $80 as of Q3 2026.
Oric Pharmaceuticals was a new ORG Wealth Partners position in Q3 2026.
Oric Pharmaceuticals made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2476 holding.
73 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.